SCHEMBL16328478

SCHEMBL16328478

CC(=O)N[C@@H](CC(=O)NCCNCCN)C(=O)N[C@H](CC(C)C)C(=O)NCCOCCOCCN=[N+]=[N-]

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CTSL P07711 2/20 0.41
▸ CTSB P07858 2/20 0.41
▸ PSMB11 A5LHX3 4/20 0.39
▸ PSMD11 O00231 4/20 0.39
▸ PSMD12 O00232 4/20 0.39
▸ PSMD14 O00487 4/20 0.39
▸ PSMA7 O14818 4/20 0.39
▸ PSMD3 O43242 4/20 0.39
▸ PSMC3 P17980 4/20 0.39
▸ PSMB1 P20618 4/20 0.39
▸ PSMA1 P25786 4/20 0.39
▸ PSMA2 P25787 4/20 0.39
▸ PSMA3 P25788 4/20 0.39
▸ PSMA4 P25789 4/20 0.39
▸ PSMB8 P28062 4/20 0.39
▸ PSMB9 P28065 4/20 0.39
▸ PSMA5 P28066 4/20 0.39
▸ PSMB4 P28070 4/20 0.39
▸ PSMB6 P28072 4/20 0.39
▸ PSMB5 P28074 4/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16328494 0.99 CTSL (0.41) CTSLCTSBPSMB11PSMD11PSMD12
SCHEMBL16328495 0.94 SIRT6 (0.34) CTSLCTSBPSMB11PSMD11PSMD12
SCHEMBL16328487 0.94 SIRT6 (0.34) CTSLCTSBPSMB11PSMD11PSMD12
SCHEMBL16328488 0.94 SIRT6 (0.34) CTSLCTSBPSMB11PSMD11PSMD12
SCHEMBL16328489 0.94 SIRT6 (0.34) CTSLCTSBPSMB11PSMD11PSMD12
SCHEMBL16328499 0.90 PSMB5 (0.47) PSMB11PSMD11PSMD12PSMD14PSMA7
SCHEMBL16328492 0.85 PSMB11 (0.32) PSMB11PSMD11PSMD12PSMD14PSMA7
SCHEMBL16328486 0.85 TDP1 (0.35) CTSLCTSBPSMB11PSMD11PSMD12
SCHEMBL13625020 0.84 CTSB (0.42) CTSLCTSBPSMB11PSMD11PSMD12
SCHEMBL13625027 0.84 CTSB (0.42) CTSLCTSBPSMB11PSMD11PSMD12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8287910-B2 Polymeric micelles for polynucleotide encapsulation INTEZYNE TECHNOLOGIES, INC. (US) 2012-10-16 — — US disclosed
US-20100278927-A1 POLYMERIC MICELLES FOR POLYNUCLEOTIDE ENCAPSULATION INTEZYNE TECHNOLOGIES, INCORPORATED (US) 2010-11-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100278927-A1 POLYMERIC MICELLES FOR POLYNUCLEOTIDE ENCAPSULATION NCL, POLN, CHMP4B CTSL 4350/4885CTSB 3462/4885PSMB11 534/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback